Evidence map›Paper›PMID 35209203›Full record

ArticleMolecules (Basel, Switzerland)2022

In Silico Study Approach on a Series of 50 Polyphenolic Compounds in Plants; A Comparison on the Bioavailability and Bioactivity Data.

Amalia Stefaniu, Lucia Camelia Pirvu

Open access · goldAbstract readComparative Study
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Polyphenol-RichNutrients · 2026
    Article
  3. Article
  4. Bioactive Polyphenolic Compounds from Propolis ofFoods (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Phytochemical profiling andFrontiers in chemistry · 2024
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amalia StefaniuDepartment of Pharmaceutical Biotechnologies, National Institute for Chemical-Pharmaceutical Research and Development, ICCF, 112 Vitan Av., 031299 Bucharest, Romania.ORCID 0000-0002-7254-7991
Lucia Camelia PirvuDepartment of Pharmaceutical Biotechnologies, National Institute for Chemical-Pharmaceutical Research and Development, ICCF, 112 Vitan Av., 031299 Bucharest, Romania.ORCID 0000-0002-5032-5079
National Institute For Chemical Pharmaceutical Research and Development · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fifty (50) phytocompounds from several subclasses of polyphenols, chosen based on their abundance in the plant world, were analyzed through density functional methods, using computational tools to evaluate their oral availability and particular bioactivity on several cell modulators; key descriptors and molecular features related to the electron density and electrostatic potential for the lowest energy conformers of the investigated molecules were computed. An analysis of the bioactivity scores towards six cell modulators (GPCR ligand, ion channel modulator, kinase inhibitor, nuclear receptor ligand, protease inhibitor and enzyme inhibitor) was also achieved, in the context of investigating their potential side effects on the human digestive processes. Summarizing, computational results confirmed in vivo and in vitro data regarding the high bioavailability of soy isoflavones and better bioavailability of free aglycones in comparison with their esterified and glycosylated forms. However, by a computational approach analyzing Lipinski's rule, apigenin and apigenin-7-

Indexed as

Computer SimulationDatabases, FactualPhytochemicalsPolyphenolsBiological AvailabilityHumansPhytochemicalsPolyphenolsbioactivityenzyme inhibitorGPCR ligandin silico studyion channel modulatorkinase inhibitornuclear receptor ligandoral bioavailabilityplant phenolicsprotease inhibitor

Identifiers

PMID35209203
PMCPMC8878759
OpenAlexW4214618745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.